Sun Pharma announced the availability of Kapspargo Sprinkle (metoprolol succinate extended-release) for the treatment of hypertension in patients aged ≥6 years; for long-term treatment of angina pectoris, to reduce angina attacks and to improve exercise tolerance; and to reduce the risk of cardiovascular mortality and heart failure hospitalization in patients with heart failure.

Kapspargo Sprinkle is the first extended-release sprinkle formulation of metoprolol succinate, a beta1-selective (cardioselective) adrenoreceptor blocking agent. For patients unable to swallow an intact capsule, the pellets can be sprinkled over soft food (eg, applesauce, yogurt, pudding) or given via a nasogastric (NG) tube. Each pellet serves as a separate drug delivery unit that provides metoprolol continuously over the dosage interval. 

Kapspargo Sprinkle is available as 25mg, 50mg, 100mg, and 200mg strength capsules in 30-count bottles. For patients taking metoprolol succinate extended-release tablets at a dose of 25mg to 200mg daily, Kapspargo Sprinkle may be substituted for the tablets using the same total daily dose of metoprolol succinate.

Continue Reading

For more information call (800) 406-7984 or visit

Related Articles

This article originally appeared on MPR